RE:RE:New Press Release - THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSA pity this isn't the actual Phase III, but a trial that 'could' lead to it... another wait... welcome, but also disappointing.